Evaluation of early clinical failure criteria for gram-negative bloodstream infections

被引:26
作者
Rac, H. [1 ]
Gould, A. P. [2 ]
Bookstaver, P. B. [1 ,3 ]
Justo, J. A. [1 ,3 ]
Kohn, J. [3 ]
Al-Hasan, M. N. [4 ,5 ]
机构
[1] Univ South Carolina, Coll Pharm, Columbia, SC 29208 USA
[2] Novant Hlth, Charlotte, NC USA
[3] Prisma Hlth Richland, Columbia, SC USA
[4] Univ South Carolina, Sch Med, Columbia, SC 29208 USA
[5] Palmetto Hlth Univ, South Carolina Med Grp, Columbia, SC USA
关键词
Antibiotics; Bacteraemia; Bloodstream infection; Clinical failure; Early clinical failure; Enterobacteriaceae; Gram-negative infection; Treatment response; EMPIRICAL ANTIMICROBIAL THERAPY; ENTEROBACTERIACEAE BACTEREMIA; NOSOCOMIAL INFECTIONS; BETA-LACTAMS; SCORE; ADULTS; DURATION; RISK; STRATIFICATION; CEPHALOSPORINS;
D O I
10.1016/j.cmi.2019.05.017
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The aim was the development of early clinical failure criteria (ECFC) to predict unfavourable outcomes in patients with Gram-negative bloodstream infections (GN-BSI). Methods: Adults with community-onset GN-BSI who survived hospitalization for >= 72 hr at Prisma Health-Midlands hospitals in Columbia, SC, USA from January 1, 2010 to June 30, 2015 were identified. Multivariable logistic regression was used to examine the association between clinical variables between 72 and 96 hr after GN-BSI and unfavourable outcomes (28-day mortality or hospital length of stay >14 days from GN-BSI onset). Results: Among 766 patients, 225 (29%) had unfavourable outcomes. After adjustments for Charlson Comorbidity Index and appropriateness of empirical antimicrobial therapy in multivariable model, predictors of unfavourable outcomes included systolic blood pressure <100 mmHg or vasopressor use (adjusted odds ratio (aOR) 1.8, 95% confidence interval (CI) 1.2-2.9), heart rate >100 beats/minute (aOR 1.7, 95% CI 1.1-2.5), respiratory rate >= 22 breaths/minute or mechanical ventilation (aOR 2.1, 95% CI 1.4-3.3), altered mental status (aOR 4.5, 95% CI 2.8-7.1), and white blood cell count >12 000/mm(3) (aOR 2.7, 95% CI 1.8-4.1) between 72 and 96 hr after index GN-BSI. Area under receiver operating characteristic curve of ECFC model in predicting unfavourable outcomes was 0.77 (0.84 and 0.71 in predicting 28-day mortality and prolonged hospitalization, respectively). Conclusions: Risk of 28-day mortality or prolonged hospitalization can be estimated between 72 and 96 hr after GN-BSI using ECFC. These criteria may have clinical utility in management of GN-BSI and may improve methodology of future investigations assessing response to antimicrobial therapy based on a standard evidence-based definition of early clinical failure. (c) 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:73 / 77
页数:5
相关论文
共 50 条
[41]   Evaluation of the Accelerate Pheno™ system for rapid identification and antimicrobial susceptibility testing of Gram-negative bacteria in bloodstream infections [J].
Descours, Ghislaine ;
Desmurs, Laurent ;
Thi Lam Thuy Hoang ;
Ibranosyan, Marine ;
Baume, Maud ;
Ranc, Anne-Gaelle ;
Fuhrmann, Christine ;
Dauwalder, Olivier ;
Salka, Wael ;
Vandenesch, Francois .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (08) :1573-1583
[42]   Effect of cefepime dose on mortality of patients with Gram-negative bacterial bloodstream infections: a prospective cohort study [J].
Alves, Marcelle D. ;
Ribeiro, Vanessa B. ;
Tessari, Jardel P. ;
Mattiello, Francine ;
De Bacco, Giordanna ;
Luz, Daniela I. ;
Vieira, Fabiane J. ;
Behle, Taina F. ;
Pasqualotto, Alessandro C. ;
Zavascki, Alexandre P. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (06) :1681-1687
[44]   Healthcare-associated Gram-negative bloodstream infections: antibiotic resistance and predictors of mortality [J].
Ergonul, O. ;
Aydin, M. ;
Azap, A. ;
Basaran, S. ;
Tekin, S. ;
Kaya, S. ;
Gulsun, S. ;
Yoruk, G. ;
Kursun, E. ;
Yesilkaya, A. ;
Simsek, F. ;
Yilmaz, E. ;
Bilgin, H. ;
Hatipoglu, C. ;
Cabadak, H. ;
Tezer, Y. ;
Togan, T. ;
Karaoglan, I. ;
Inan, A. ;
Engin, A. ;
Aliskan, H. E. ;
Yavuz, S. S. ;
Erdinc, S. ;
Mulazimoglu, L. ;
Azap, O. ;
Can, F. ;
Akalin, H. ;
Timurkaynak, F. .
JOURNAL OF HOSPITAL INFECTION, 2016, 94 (04) :381-385
[45]   An analysis of the incidence, causes and preventative approaches to gram-negative bloodstream infections of hepatopancreatobiliary origin [J].
Majeed, Mustafa ;
Ward, Harry ;
Wade, Cian ;
Butcher, Lisa ;
Soonawalla, Zahir ;
Bond-Smith, Giles .
JOURNAL OF INFECTION PREVENTION, 2021, 22 (03) :111-118
[46]   Frequency of Gram-negative bacterial pathogens in bloodstream infections and their resistance to antibiotics in the Czech Republic [J].
Cermák, P ;
Kolár, M ;
Látal, T .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 23 (04) :401-404
[47]   Predictive value of the kinetics of procalcitonin and C-reactive protein for early clinical stability in patients with bloodstream infections due to Gram-negative bacteria [J].
Gutierrez-Gutierrez, Belen ;
Morales, Isabel ;
Perez-Galera, Salvador ;
Fernandez-Riejos, Patricia ;
Retamar, Pilar ;
de Cueto, Marina ;
Pascual, Alvaro ;
Rodriguez-Bano, Jesus .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 93 (01) :63-68
[48]   Nosocomial bloodstream infections caused by gram-negative bacilli:: epidemiology and risk factors for mortality [J].
Lizaso, Diego ;
Aguilera C, Karina ;
Correa, Malena ;
Laura, Maria ;
Mario Cuitino, Yantorno ;
Perez, Lorena ;
Lares, Monica ;
de la Parra, Gloria ;
Esposto, Amadeo .
REVISTA CHILENA DE INFECTOLOGIA, 2008, 25 (05) :368-373
[49]   Association Between Body Mass Index and Mortality in Patients With Gram-Negative Bloodstream Infections [J].
Lines, Jacob ;
Yang, Zhengguan ;
Bookstaver, Paul Brandon ;
Catchings, Erin ;
Justo, Julie Ann ;
Kohn, Joseph ;
Albrecht, Helmut ;
Al-Hasan, Majdi N. .
INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2019, 27 (02) :90-95
[50]   Gram-Negative Bloodstream Infection: Implications of Antimicrobial Resistance on Clinical Outcomes and Therapy [J].
Al-Hasan, Majdi N. .
ANTIBIOTICS-BASEL, 2020, 9 (12)